Targeting of insulin-like growth factor type 1 receptor in Ewing sarcoma: unfulfilled promise or a promising beginning?

J Clin Oncol. 2011 Dec 1;29(34):4581-3. doi: 10.1200/JCO.2011.38.2374. Epub 2011 Oct 24.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Female
  • Humans
  • Immunoglobulins, Intravenous
  • Male
  • Receptor, IGF Type 1 / immunology*
  • Sarcoma, Ewing / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Immunoglobulins, Intravenous
  • Receptor, IGF Type 1
  • figitumumab
  • teprotumumab